• Return to Headlines

Accelerate Diagn Shares Up 51.3% Since SmarTrend's Buy Recommendation (AXDX)

By James Quinn

SmarTrend identified an Uptrend for Accelerate Diagn (NASDAQ:AXDX) on January 7th, 2019 at $13.44. In approximately 2 months, Accelerate Diagn has returned 51.34% as of today's recent price of $20.34.

Over the past year, Accelerate Diagn has traded in a range of $10.23 to $27.65 and is now at $20.34, 99% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 3.2% while the 200-day MA has remained constant.

Accelerate Diagnostics, Inc. operates as a vitro diagnostics company. The Company develops diagnostic systems for bacterial infections. Accelerate Diagnostics serves the healthcare sector globally.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Accelerate Diagn shares.

Log in and add Accelerate Diagn (AXDX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights accelerate diagn

Ticker(s): AXDX